Search results for "Calciphylaxis"

showing 9 items of 9 documents

Kalziphylaxie: Ischämische Hautnekrosen bei terminaler Niereninsuffizienz

2000

Calciphylaxis is a rare but potentially life-threatening complication in chronic renal failure. It is characterized by ischemic tissue necrosis primarily of the skin. The typical histopathologic finding is microvascular calcification with endovascular fibrosis. Patients typically present with violaceous, mottled and painful lesions which tend to progress to non-healing ulcers and necrosis. Most frequently the lower extremities are involved in a symmetric fashion but the trunk may also be affected. Sepsis from superinfection of the lesions accounts for the high mortality of this disease which is of importance for dermatologists and nephrologists alike. 61-year-old female patient developed le…

Calciphylaxismedicine.medical_specialtymedicine.diagnostic_testbusiness.industrymedicine.medical_treatmentDermatologymedicine.diseaseDermatologySepsisFibrosisBiopsyMedicineHemodialysisbusinessComplicationCalcificationKidney diseaseDer Hautarzt
researchProduct

Pain reduction by dehydrated human amnion/chorion membrane allograft in nondiabetic leg ulcers might be an early indicator of good response: A case s…

2020

Dehydrated human amnion/chorion membrane allograft (dHACM) derived from placenta is increasingly used for skin and soft tissue repair in several medical specialties. Promising effects of dHACM were also reported in chronic venous and diabetic leg ulcers. However, dHACM is cost-intensive and its effect on chronic leg ulcers of other etiologies and pain reduction is unknown. Clinical predictors of a favorable response to dHACM during the early treatment period could help to limit unnecessary costs. In our case series with six patients suffering from chronic lower leg ulcers of various etiology, the effect of dHACM once per week on reduction of pain and wound size during a 5-week period was ex…

Chronic woundmedicine.medical_specialtyPainDermatology030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineMedicineHumansAmnionCalciphylaxisAmnionbusiness.industryLeg UlcerDehydrated Human Amnion/Chorion MembraneReactive angioendotheliomatosisGeneral MedicineChorionmedicine.diseaseAllograftsSurgerymedicine.anatomical_structurePain reduction030220 oncology & carcinogenesisEtiologymedicine.symptombusinessWound healingDermatologic therapyREFERENCES
researchProduct

A novel nonsense mutation in exon 2 of the factor IX gene resulting in severe haemophilia B

2006

GeneticsCalciphylaxismedicine.diagnostic_testbusiness.industrymedia_common.quotation_subjectNonsense mutationNonsensemedicine.diseaseExonEmergency MedicineInternal MedicineMedicineHaemophilia BbusinessGeneGenetic testingFactor IXmedicine.drugmedia_commonInternal and Emergency Medicine
researchProduct

Non-valvular Atrial Fibrillation in CKD: Role of Vitamin K Antagonists and Direct Oral Anticoagulants. A Narrative Review

2021

Atrial fibrillation (AF) is the most common arrhythmia in chronic kidney disease (CKD), with a close bidirectional relationship between the two entities. The presence of CKD in AF increases the risk of thromboembolic events, mortality and bleeding. Vitamin K antagonists (VKA) have been the mainstay of treatment for the prevention of thromboembolic events in AF until recently, with confirmed benefits in AF patients with stage 3 CKD. However, the risk-benefit profile of VKA in patients with AF and stages 4–5 CKD is controversial due to the lack of evidence from randomized controlled trials. Treatment with VKA in CKD patients has been associated with conditions such as poorer anticoagulation q…

Medicine (General)medicine.medical_specialtyVitamin KMini ReviewLower riskurologic and male genital diseaseslaw.inventionDirect oral anticoagulantsR5-920Randomized controlled triallawInternal medicineFibril·lació auricularMalalties cròniquesMedicineatrial fibrillationStrokeCalciphylaxisKidney diseasesbusiness.industryWarfarinAcute kidney injuryanticoagulant-related nephropathyAtrial fibrillationGeneral Medicinemedicine.diseaseVitamines KAtrial fibrillationfemale genital diseases and pregnancy complicationsVitamin K antagonistsArítmiaChronic diseasesInsuficiència renal crònicaAnticoagulants (Medicina)CardiologyMalalties del ronyóMedicineAnticoagulants (Medicine)businesschronic kidney diseasemedicine.drugKidney diseaseFrontiers in Medicine
researchProduct

A complex case of fatal calciphylaxis in a female patient with hyperparathyroidism secondary to end stage renal disease of graft and coexistence of h…

2012

Background: Calciphylaxis is a potentially fatal complication of persistent secondary hyperparathyroidism; its cause is still not clear. Unfortunately there is no close relation in severity of clinical picture, serological and pathological alteration. For this reason the prognosis is difficult to establish. Administration of sodium thiosulphate may reduce the precipitation of calcium crystals and improve the general clinical conditions before surgical parathyroidectomy, which seems the only therapeutic approach able to reduce the mortality risk in these patients. Methods and Results: A 60 year old female patient suffering from End Renal Stage Disease, on haemodialysis from 2001 due to the o…

ParathyroidectomyGraft Rejectionmedicine.medical_specialtymedicine.medical_treatmentCalciphylaxiSettore MED/08 - Anatomia PatologicaGeneral Biochemistry Genetics and Molecular BiologyEnd stage renal diseaseFatal OutcomeSecondary hyperparathyroidism; Calciphylaxis; Kidney transplant; ParathyroidectomymedicineHumansKidney transplantDialysisParathyroidectomySettore MED/14 - NefrologiaCalciphylaxisHyperparathyroidismbusiness.industryCalciphylaxisMiddle Agedmedicine.diseaseKidney TransplantationSurgeryTransplantationSecondary hyperparathyroidismSettore MED/18 - Chirurgia GeneraleHemolytic-Uremic SyndromeKidney Failure ChronicSecondary hyperparathyroidismFemaleHyperparathyroidism SecondaryComplicationbusinessBiomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia
researchProduct

Sistemic calciphylaxis and thrombotic microangiopathy in a kidney transplant patient: Two mixing fatal syndromes?

2012

Abstract Abnormalities in calcium and phosphorus metabolism are common and metabolic bone diseases develop often in patients with chronic renal failure (CRF). Effective clinical management includes measures to control phosphorus retention and prevent hyperphosphataemia, to maintain serum calcium concentrations within the normal range and to prevent excess parathyroid hormone (PTH) secretion by the judicious use of vitamin D sterols. Certain of these interventions, however, appear to increase the risk of soft tissue and vascular calcification in patients with End Stage Renal Disease (ESRD), so current therapeutic approaches are thus being re-evaluated in an effort to limit these risks. Patie…

Parathyroidectomymedicine.medical_specialtyPathologyCalciplhylaxisThrombotic microangiopathymedicine.medical_treatmentHemolitic Huremic SyndromeSettore MED/08 - Anatomia PatologicaGastroenterologyPhosphorus metabolismEnd stage renal diseaseInternal medicineSettore MED/35 - Malattie Cutanee E VenereemedicineHumansKidney transplantationSettore MED/14 - NefrologiaCalciphylaxisThrombotic Microangiopathiesbusiness.industryCalciphylaxisEnd Stage Renal Disease; Hemolitic Huremic Syndrome; CalciplhylaxisGeneral MedicineModels Theoreticalmedicine.diseaseKidney TransplantationSettore MED/18 - Chirurgia GeneraleSecondary hyperparathyroidismEnd Stage Renal DiseasebusinessCalcificationMedical Hypotheses
researchProduct

Dermatopatología de la oclusión intraluminal vascular: parte II (coagulopatías, émbolos y miscelánea)

2021

Resumen: La patología vascular oclusiva es causante de diversas y variadas manifestaciones clínicas, algunas de ellas con catastróficas consecuencias para el paciente. Dado que las causas de tal oclusión son muy variadas, hemos abordado en un artículo previo reciente en esta misma revista las causas trombóticas. En el presente artículo recopilamos diversas causas adicionales de oclusión intravascular. Abstract: Vascular occlusion has multiple, diverse clinical manifestations, some of which can have grave consequences for patients. It also has a wide variety of causes, including thrombi, which we recently addressed in part I of this review. In this second part, we look at additional causes o…

Pathologymedicine.medical_specialtybusiness.industryCalciphylaxisGeneral MedicineDermatologyDisseminated intravascular coagulationVascular occlusionRC31-1245030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineLivedoid vasculopathy030220 oncology & carcinogenesisRL1-803medicineBlood coagulation disordersmedicine.symptombusinessDegos diseaseInternal medicineCoagulation DisorderActas Dermo-Sifiliográficas
researchProduct

Calciphylaxie : une complication grave et méconnue de l'insuffisance rénale chronique terminale. À propos de deux cas

2005

Calciphylaxis presents like subcutaneous lesions with livedo reticularis leading to necrotic and painful ulcers, predominantly in the lower limbs and the abdomen. They initially simulate dermohypodermitis. Biology reveals secondary hyperparathyroidism, phosphocalcic metabolism abnormalities and state of hypercoagulability. Histological signs are constant: calcifications in the media of small and sub-cutaneous arteries, intimal hyperplasia and intravascular thrombosis. This complication occurs in 4% of end-stage renal disease patients. Its prognostic is awful with a rate of mortality of 60% due to sepsis. Treatment is based upon the normalization of phosphocalcic rates and local debridement.

medicine.medical_specialtyCalciphylaxisHyperparathyroidismIntimal hyperplasiabusiness.industrymedicine.diseaseSurgeryEnd stage renal diseaseMedicineSurgerySecondary hyperparathyroidismmedicine.symptombusinessComplicationLivedo reticularisKidney diseaseAnnales de Chirurgie Plastique Esthétique
researchProduct

Sodium thiosulfate not always resolves calciphylaxis: an ambiguous response

2011

Calciphylaxis is a severe “vascular ossification–calcification,” associated with a very high mortality rate that involvesarterial wall, venular wall, and nerves resulting in ischemia and necrosis of skin, subcutaneous fat, visceral organs,and skeletal muscles. Sodium thiosulfate has recently been used as a novel treatment option for calciphylaxisbecause of its dual role as an antioxidant and a chelator. Multiple case reports demonstrated that such therapy hasresulted in pain relief and healing of skin ulceration. We report a case of calciphylaxis of large severity that had anambiguous response to sodium thiosulfate treatment (improvement of symptomatology and skin lesions, improve-ment of b…

medicine.medical_specialtyNecrosisSettore MED/09 - Medicina InternaIschemiaThiosulfatesSodium thiosulfateCritical Care and Intensive Care MedicineGastroenterologySubcutaneous fatSeverity of Illness IndexAntioxidantschemistry.chemical_compoundFatal OutcomeInternal medicineSeverity of illnessmedicineHumansChelating AgentsThiosulfateCalciphylaxisbusiness.industryCalciphylaxisGeneral MedicineMiddle Agedmedicine.diseasethiosulfate calciphylaxisSurgeryTreatment OutcomechemistryNephrologyFemalemedicine.symptombusinessBlood parameters
researchProduct